The BIG attempt to deliver more efficient care by limiting hospital and ICU admissions to patients who truly require them, decreasing unnecessary radiographic testing, and reserving specialist consultation for appropriate scenarios. This study attempts to assess how accurate the BIG are at identifying patients that may be eligible for this less aggressive management algorithm. The findings of this project suggest that EDHs have a high risk of both radiographic and clinical progression. Those patients that had clinical decompensation were both EDHs who were identified on examination and progressed within the first 24 hours of admission. Both required neurosurgical intervention. Otherwise, the original BIG were accurate at identifying low-risk patients with mild TBI at the three institutions participating in this project.
Currently, most patients who suffer a TBI with ICH will be admitted to the hospital. Under the BIG, patients who fall into the BIG 1 category do not require an inpatient admission and instead are discharged after a 6 hour observation period in the ED. Utilization of these guidelines during the study period could have led to a 98 fewer admissions with a potential decrease of 339 hospital days for those patients. This represents a tremendous source of potential cost savings if the guidelines were widely implemented.
The concept that neurosurgical consultation is not warranted in all patients with traumatic ICH is not new.5 6 8–10 14 The question as to which patients need a neurosurgical consultation and which patients can be managed solely by trauma surgeons has been difficult to answer.9 10 14 The BIG offer a framework by which this question can be systematically approached.12 13 Neurosurgeons would be free to focus on those patients that are most likely to need their operative services, avoiding costly and time-consuming consults for patients with relatively minor head injuries.
The question of whether all patients with mild TBI (GCS 13 to 15) and ICH need a repeat head CT has been posed for several years.3 7 9 11 15–20 This emerging literature suggests that the selective use of repeat CT scan in TBI is safe, but a consensus as to which patients do not require repeat CT has not been reached. Using GCS alone to estimate the severity of TBI is inadequate.21 The BIG use the size of ICH to analyze the need for scheduled repeat head CT and save repeat head CT for the largest volume ICH or for patients that have a change in neurologic examination. Implementation of the BIG during the study period would have resulted in 370 fewer CT scans which is an average of 1.38 repeat CT scans per patient. Widespread adoption of these guidelines has the potential to significantly impact the vast sums spent on TBI each year, merely from the decrease in CT scans obtained.
Improvements in resource allocation are of no utility if patient safety is not preserved. When considering TBI, the potential sequelae of missed progression of injury are so devastating that they must be kept to an absolute minimum. This retrospective analysis found that more stringent criteria with regard to EDH are warranted to ensure that injury progression is not missed. Additionally, the BIG lack clarity regarding several of the components. Any attempt to implement the guidelines across institutions would require speculation as to how to define some important aspects of the algorithm.12 13
Proposal of modified Brain Injury Guidelines
Based on the findings of this study and an assessment into the reproducibility of the original BIG, the modified Brain Injury Guidelines (mBIG) are proposed (figure 2). These modifications to the original guidelines were created by a combined effort from the trauma and neurosurgery departments at the participating institutions. Overall, the modifications can be categorized as changes to either increase patient safety or to allow for consistent, widespread utilization of the guidelines.
Figure 2Modified Brain Injury Guidelines. BIG, Brain Injury Guidelines; ED, emergency department; EDH, epidural hematoma; EtOH, blood alcohol level; fx, fracture; GCS, Glasgow Coma Scale score; ICH, intracranial hemorrhage; IPH, intraparenchymal hematoma; IVH, intraventricular hemorrhage; mBIG, modified BIG; SAH, subarachnoid hemorrhage; SDH, subdural hematoma; TBI, traumatic brain injury.
The original BIG retrospective analysis found radiographic progression in 0% of BIG 1 patients and 2.6% of BIG 2 patients.12 The current study found the rate of radiographic progression to be much higher at 11.2% for BIG 1 patients and 11.1% for BIG 2 patients. Although the rate of radiographic progression was higher in this analysis, radiographic progression alone was not clinically significant. This is consistent with the findings of the original BIG retrospective review. Deterioration on neurologic examination was a much more important clinical indicator.
The most critical component of the mBIG that differs from the original BIG is that all EDH are classified as mBIG 3. This study suggests that EDH carry an unacceptable risk for clinical progression of injury. Two patients with EDH, both of whom qualified as BIG 2, had both clinical and radiographic decompensation and required decompressive craniectomy. Although there is debate as to the utility of craniectomy, these are the only BIG 1 or 2 patients that experienced a deterioration in neurologic examination.22–25 In addition, patients with EDH were more than eight times more likely to have a radiographic progression of CT findings on multivariable analysis, although this study did evaluate a small sample size. In the interest of patient safety, the mBIG classify any EDH as a mBIG 3.
The original BIG classify any patient taking aspirin, warfarin, or clopidogrel at the time of injury as BIG 3. In addition to those three medications, the mBIG include direct oral anticoagulants (DOACs), including oral factor Xa inhibitors and direct thrombin inhibitors, as an indication to classify the patient as mBIG 3. DOACs are becoming more commonplace and the risk of progression of hemorrhage after ICH in patients taking these medications is not clearly understood but may be significant.26–28
In order for any set of guidelines to be implemented, they must be generalizable across different providers and institutions. Several of the definitions used in the original BIG require clarification to be widely implementable.
The original BIG define SAHs as “trace,” “localized,” or “scattered” to qualify as BIG 1, 2, or 3, respectively.12 These definitions are vague and cannot be consistently applied without clarification. The mBIG propose new definitions based on the number of involved sulci and hemispheres that are easily reproducible and can be consistently applied across institutions and practitioners.
The original guidelines suggest that “intoxication” excludes a patient from consideration as BIG 1; however, they do not define intoxication. The mBIG define intoxication as a blood alcohol level of 80 mg/dL or greater, consistent with the legal limit for driving in the USA.29 Due to the lack of a reliable timeline from ingestion to positive test in patients with positive urine toxicity screening, use of other illicit drugs was not considered an indication to exclude a patient from consideration as an mBIG 1. Patients are required to have a normal neurologic examination to be classified as mBIG 1 or 2, as in the original guidelines. Any patient under the influence of drugs with an abnormal neurologic examination would be considered mBIG 3 due to altered mental status.
Treatment algorithms in the original BIG are clear for BIG 1 patients, but are lacking for BIG 2 patients. The original guidelines merely state that BIG 2 patients should be admitted to the hospital without a repeat head CT or neurosurgical consultation.12 13 There is no discussion of the duration or location of admission. The mBIG algorithm clarifies that mBIG 2 patients are admitted for 24 to 48 hours with neurologic assessments every 2 hours for the first 6 hours and every 4 hours thereafter. Since no patient in this review experienced a clinical decompensation other than those with EDH, 24 to 48 hours of observation is sufficient to ensure clinical stability and to allow for discharge as part of the team’s normal workflow. Unlike the original guidelines, all mBIG 1 and 2 patients must have a GCS of 15 to be discharged. As with the original guidelines, any deterioration in neurologic examination immediately elevates any patient classified as mBIG 1 or 2 to the mBIG 3 arm of therapy with a repeat head CT, neurosurgical consultation, and hospital admission.
There are several limitations to this study. As a multicenter retrospective, database study, it is subject to the limitations inherent to this type of study, including a reliance on correct coding and the variability in patient management across providers and institutions. The analysis into resource utilization is limited due to the dearth of data on true hospital costs. Ideally, the hospital costs incurred by these patients could have been directly analyzed and reported; however, this information is not readily available for publication. Without reliable data regarding average hospital costs, assigning monetary values to potential cost savings is not possible. Additionally, concomitant injuries undoubtedly played a role in some hospital and ICU admissions, but the ability to accurately quantify that role is limited in a retrospective review. Clinical decision making processes at the time of admission, hospitalization, and discharge are not always readily apparent when looking retrospectively. This project highlights the potential for great cost savings with the implementation of these guidelines, but the exact cost reduction cannot be accurately analyzed from a retrospective review.